Mysulin Injection 30%+70% is a premixed insulin formulation containing Regular Insulin Human 30% (short-acting) and Isophane Insulin Human 70% (intermediate-acting) in a concentration of 100 IU/ml. This combination provides both rapid and prolonged insulin action in a single injection, making it ideal for patients with diabetes mellitus who require effective control of both postprandial (after meals) and fasting blood glucose levels.
The Regular Insulin Human component acts quickly to reduce blood sugar spikes following meals, while the Isophane Insulin Human component provides a slower, sustained release to maintain basal insulin coverage throughout the day. This premixed formulation offers convenience, reduces the number of daily injections, and helps patients adhere to their insulin regimen effectively.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Mysulin Injection 30%+70% is indicated for:
Type 1 diabetes mellitus – for patients requiring both basal and prandial insulin coverage
Type 2 diabetes mellitus – when oral antidiabetic drugs alone are insufficient to maintain glycemic control
Management of hyperglycemia, including both fasting and postprandial blood sugar levels
Patients needing a simplified insulin regimen with fewer injections while maintaining effective blood glucose control
This premixed insulin is suitable for adults and adolescents and is often used under the supervision of a healthcare professional to achieve individualized glycemic targets.
Controls post-meal blood sugar spikes with rapid-acting insulin
Maintains basal blood sugar levels with intermediate-acting insulin
Simplifies treatment regimen by combining two insulin types in one injection
Helps prevent long-term complications of diabetes, such as neuropathy, retinopathy, and cardiovascular diseases
Suitable for home use, travel, and flexible daily schedules
By providing dual-phase insulin coverage, Mysulin Injection 30%+70% ensures stable glycemic control and supports better quality of life for diabetic patients.
The dosage must be individualized based on blood glucose levels, diet, activity, and other medications.
Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy.
Typically given one to two times daily, usually before meals, as prescribed by a healthcare provider.
Do not mix with other insulins unless specifically advised by a physician.
Regular blood glucose monitoring is essential to adjust doses and avoid hypoglycemia or hyperglycemia.
Hypoglycemia is a potential risk; recognize early symptoms such as sweating, shakiness, and dizziness.
Adjust doses during illness, stress, dietary changes, or increased physical activity.
Inform your physician about all medications to prevent interactions affecting blood sugar levels.
Pregnant or breastfeeding women should use this injection under medical supervision.
Always keep a source of fast-acting sugar for emergency management of low blood sugar.
Mysulin Injection 30%+70% is generally well tolerated. Potential side effects may include:
Hypoglycemia (low blood sugar)
Injection site reactions such as redness, swelling, or mild pain
Weight gain with long-term therapy
Rare allergic reactions, including rash or anaphylaxis
Most side effects are mild and manageable with proper dose adjustment and monitoring.
Store unopened vials in a refrigerator at 2–8°C. Do not freeze.
After opening, it may be kept at room temperature (below 30°C) for a limited period as advised by your physician.
Protect from light and moisture, and keep out of reach of children.
Mysulin Injection 30%+70% (Regular Insulin Human + Isophane Insulin Human) is a reliable premixed insulin that provides both rapid and intermediate action, helping patients maintain stable blood glucose levels and achieve effective diabetes management.
Login Or Registerto submit your questions to seller
No none asked to seller yet